Related Experiment Videos
Comparative genomic hybridization: a new tool for reproductive pathology
I J Barrett1, B L Lomax, T Loukianova
1Department of Pathology & Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.
Archives of Pathology & Laboratory Medicine
|January 11, 2001
Summary
Comparative genomic hybridization (CGH) effectively detects aneuploidy in reproductive tissues, proving valuable for spontaneous abortions and term placentas. This genomic tool aids clinical cytogenetics by bypassing culture issues and identifying genetic abnormalities.
Area of Science:
- Reproductive genetics
- Clinical cytogenetics
- Genomic analysis
Background:
- Reproductive pathology specimens require accurate genetic analysis for diagnosis.
- Traditional cytogenetic methods can be limited by tissue culture failures and artifacts.
Purpose of the Study:
- To evaluate the clinical utility of comparative genomic hybridization (CGH) in analyzing reproductive pathology specimens.
- To demonstrate CGH's effectiveness in identifying aneuploidy in fetal and placental tissues within a clinical cytogenetics setting.
Main Methods:
- Performed 856 CGH analyses on placental and fetal tissues from spontaneous abortions and pregnancies with live-born infants.
- Included specimens from normally developed infants, those with intrauterine growth restriction, and abnormal prenatal screens.
Main Results:
- CGH analysis was successful in 98.4% of the 856 reproductive specimens.
- Identified aneuploidy in 53% of spontaneous abortion samples.
- Detected aneuploidy in 3.1% of term placenta samples.
Conclusions:
- Comparative genomic hybridization is a valuable clinical tool for detecting aneuploidy in reproductive tissues.
- CGH offers a genome-wide screening approach, overcoming limitations of tissue culture.
- Guidelines for interpreting CGH profiles from human reproductive specimens are provided.